Vial Presents: Challenges in Oncology Clinical Trials, Opportunities for Tech with Dr. Brian Rini

Rich McCormick, VP of Oncology at Vial joins Dr. Brian Rini, Chief of Clinical Trials at Vanderbilt Ingram Cancer Center to delve into the challenges of conducting oncology trials and the potential for technological advancements. Dr. Rini highlights the need for streamlined data transfer, automated processes for budget creation, and envisions a future where wearable devices and telehealth revolutionize the efficiency of clinical trials, ultimately benefiting patients and researchers alike.
To view the full episode transcript, click here: bit.ly/49EvWln
-------
About Vial: Vial is a tech-enabled, next-generation CRO that promises faster and higher-quality execution of trials. The Vial Contract Research Organization (CRO) delivers on the promise of more efficient trials through its innovative technology platform that powers trials end-to-end from site startup to database lock. The key to Vial's tech-enabled platform is Vial's modern, intuitive Electronic Source and powerful tooling for CRAs that enables considerable efficiencies. Vial operates across multiple therapeutic areas (Dermatology CRO, Ophthalmology CRO, Oncology CRO, Gastroenterology CRO, Neurology CRO, and Cardiology CRO). Vial is a San Francisco, California-based company with over 125 employees.
🎧 Stay in the Loop!
For the latest news and updates, visit our website: vial.com
Follow us on social media for real-time insights:
Twitter:
/ vialtrials
LinkedIn:
/ vialtrials